Status:

UNKNOWN

Functional Treatment Planning Utilizing 18-FDGal PET/CT in SBRT for Liver Metastases

Lead Sponsor:

University of Aarhus

Collaborating Sponsors:

Danish Cancer Society

Conditions:

Liver Metastases

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Background: Anatomical (traditional) stereotactic body radio therapy(SBRT) treatment planning assumes homogenous distribution of function in the normal liver tissue. In functional treatment planning, ...

Eligibility Criteria

Inclusion

  • Performance status \>2
  • liver metastases refereed for SBRT

Exclusion

  • pregnancy
  • claustrophobia

Key Trial Info

Start Date :

August 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2016

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT01861873

Start Date

August 1 2013

End Date

March 1 2016

Last Update

May 24 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Aarhus University Hospital

Aarhus C, Denmark, 8000

Functional Treatment Planning Utilizing 18-FDGal PET/CT in SBRT for Liver Metastases | DecenTrialz